nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—SCN1B—type 2 diabetes mellitus	0.479	0.946	CbGaD
Zonisamide—CYP3A4—type 2 diabetes mellitus	0.0273	0.0539	CbGaD
Zonisamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0182	0.108	CbGbCtD
Zonisamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0155	0.0918	CbGbCtD
Zonisamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0155	0.0918	CbGbCtD
Zonisamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0143	0.0847	CbGbCtD
Zonisamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0138	0.0818	CbGbCtD
Zonisamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0116	0.0689	CbGbCtD
Zonisamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0103	0.0614	CbGbCtD
Zonisamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00945	0.0561	CbGbCtD
Zonisamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00826	0.0491	CbGbCtD
Zonisamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00791	0.047	CbGbCtD
Zonisamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00747	0.0444	CbGbCtD
Zonisamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00723	0.043	CbGbCtD
Zonisamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00566	0.0336	CbGbCtD
Zonisamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00543	0.0322	CbGbCtD
Zonisamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00543	0.0322	CbGbCtD
Zonisamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00513	0.0305	CbGbCtD
Zonisamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00382	0.0227	CbGbCtD
Zonisamide—CA8—artery—type 2 diabetes mellitus	0.00377	0.0672	CbGeAlD
Zonisamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0035	0.0208	CbGbCtD
Zonisamide—CA13—nerve—type 2 diabetes mellitus	0.0032	0.057	CbGeAlD
Zonisamide—SCN11A—peripheral nervous system—type 2 diabetes mellitus	0.00281	0.0501	CbGeAlD
Zonisamide—SCN11A—nerve—type 2 diabetes mellitus	0.00219	0.039	CbGeAlD
Zonisamide—CA8—islet of Langerhans—type 2 diabetes mellitus	0.00181	0.0323	CbGeAlD
Zonisamide—SCN2B—cardiovascular system—type 2 diabetes mellitus	0.00154	0.0275	CbGeAlD
Zonisamide—SCN1B—cardiovascular system—type 2 diabetes mellitus	0.00139	0.0248	CbGeAlD
Zonisamide—CA8—cardiovascular system—type 2 diabetes mellitus	0.00131	0.0233	CbGeAlD
Zonisamide—CA11—islet of Langerhans—type 2 diabetes mellitus	0.0013	0.0232	CbGeAlD
Zonisamide—CA10—cortex of kidney—type 2 diabetes mellitus	0.00127	0.0227	CbGeAlD
Zonisamide—SCN1B—adipose tissue—type 2 diabetes mellitus	0.00123	0.0219	CbGeAlD
Zonisamide—CA8—adipose tissue—type 2 diabetes mellitus	0.00115	0.0206	CbGeAlD
Zonisamide—SCN3B—adipose tissue—type 2 diabetes mellitus	0.00113	0.0202	CbGeAlD
Zonisamide—CA11—retina—type 2 diabetes mellitus	0.00111	0.0198	CbGeAlD
Zonisamide—CA13—pancreas—type 2 diabetes mellitus	0.00109	0.0194	CbGeAlD
Zonisamide—CA13—adipose tissue—type 2 diabetes mellitus	0.000988	0.0176	CbGeAlD
Zonisamide—SCN4B—adipose tissue—type 2 diabetes mellitus	0.000963	0.0172	CbGeAlD
Zonisamide—CA1—nerve—type 2 diabetes mellitus	0.000919	0.0164	CbGeAlD
Zonisamide—CA11—pancreas—type 2 diabetes mellitus	0.000914	0.0163	CbGeAlD
Zonisamide—CA11—cortex of kidney—type 2 diabetes mellitus	0.000896	0.016	CbGeAlD
Zonisamide—SCN1B—liver—type 2 diabetes mellitus	0.000861	0.0154	CbGeAlD
Zonisamide—CA11—adipose tissue—type 2 diabetes mellitus	0.000829	0.0148	CbGeAlD
Zonisamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00076	0.0135	CbGeAlD
Zonisamide—MAOB—nerve—type 2 diabetes mellitus	0.000746	0.0133	CbGeAlD
Zonisamide—CA4—nerve—type 2 diabetes mellitus	0.000718	0.0128	CbGeAlD
Zonisamide—CA13—liver—type 2 diabetes mellitus	0.000693	0.0124	CbGeAlD
Zonisamide—MAOA—nerve—type 2 diabetes mellitus	0.000636	0.0113	CbGeAlD
Zonisamide—CA7—kidney—type 2 diabetes mellitus	0.000612	0.0109	CbGeAlD
Zonisamide—CA5A—liver—type 2 diabetes mellitus	0.000581	0.0104	CbGeAlD
Zonisamide—CA3—cardiovascular system—type 2 diabetes mellitus	0.000574	0.0102	CbGeAlD
Zonisamide—SCN9A—nephron tubule—type 2 diabetes mellitus	0.000568	0.0101	CbGeAlD
Zonisamide—CA3—adipose tissue—type 2 diabetes mellitus	0.000506	0.00903	CbGeAlD
Zonisamide—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.000478	0.00853	CbGeAlD
Zonisamide—AOX1—islet of Langerhans—type 2 diabetes mellitus	0.000469	0.00836	CbGeAlD
Zonisamide—SCN9A—adipose tissue—type 2 diabetes mellitus	0.00045	0.00803	CbGeAlD
Zonisamide—SCN4A—kidney—type 2 diabetes mellitus	0.000446	0.00795	CbGeAlD
Zonisamide—SCN4A—adipose tissue—type 2 diabetes mellitus	0.000402	0.00716	CbGeAlD
Zonisamide—CA12—kidney—type 2 diabetes mellitus	0.000398	0.00709	CbGeAlD
Zonisamide—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.000384	0.00685	CbGeAlD
Zonisamide—AOX1—nephron tubule—type 2 diabetes mellitus	0.000377	0.00673	CbGeAlD
Zonisamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000364	0.0065	CbGeAlD
Zonisamide—CA3—liver—type 2 diabetes mellitus	0.000355	0.00633	CbGeAlD
Zonisamide—CA5B—pancreas—type 2 diabetes mellitus	0.000354	0.00632	CbGeAlD
Zonisamide—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000353	0.0063	CbGeAlD
Zonisamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000348	0.00621	CbGeAlD
Zonisamide—SCN3A—kidney—type 2 diabetes mellitus	0.000347	0.00618	CbGeAlD
Zonisamide—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.000338	0.00602	CbGeAlD
Zonisamide—AOX1—kidney—type 2 diabetes mellitus	0.000332	0.00592	CbGeAlD
Zonisamide—AOX1—pancreas—type 2 diabetes mellitus	0.000329	0.00588	CbGeAlD
Zonisamide—AOX1—cortex of kidney—type 2 diabetes mellitus	0.000323	0.00576	CbGeAlD
Zonisamide—CA14—liver—type 2 diabetes mellitus	0.000322	0.00575	CbGeAlD
Zonisamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000322	0.00574	CbGeAlD
Zonisamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000321	0.00573	CbGeAlD
Zonisamide—CA1—kidney—type 2 diabetes mellitus	0.000315	0.00562	CbGeAlD
Zonisamide—CA1—pancreas—type 2 diabetes mellitus	0.000313	0.00558	CbGeAlD
Zonisamide—SCN3A—adipose tissue—type 2 diabetes mellitus	0.000312	0.00557	CbGeAlD
Zonisamide—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000308	0.0055	CbGeAlD
Zonisamide—AOX1—adipose tissue—type 2 diabetes mellitus	0.000299	0.00533	CbGeAlD
Zonisamide—CACNA1H—liver—type 2 diabetes mellitus	0.000296	0.00528	CbGeAlD
Zonisamide—MAOB—nephron tubule—type 2 diabetes mellitus	0.000291	0.00519	CbGeAlD
Zonisamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000288	0.00515	CbGeAlD
Zonisamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000284	0.00506	CbGeAlD
Zonisamide—CA4—nephron tubule—type 2 diabetes mellitus	0.00028	0.005	CbGeAlD
Zonisamide—MAOA—retina—type 2 diabetes mellitus	0.000263	0.0047	CbGeAlD
Zonisamide—MAOB—cardiovascular system—type 2 diabetes mellitus	0.000261	0.00466	CbGeAlD
Zonisamide—MAOB—kidney—type 2 diabetes mellitus	0.000256	0.00456	CbGeAlD
Zonisamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000252	0.00449	CbGeAlD
Zonisamide—MAOB—cortex of kidney—type 2 diabetes mellitus	0.000249	0.00444	CbGeAlD
Zonisamide—MAOA—nephron tubule—type 2 diabetes mellitus	0.000248	0.00443	CbGeAlD
Zonisamide—CA2—retina—type 2 diabetes mellitus	0.000247	0.0044	CbGeAlD
Zonisamide—CA4—kidney—type 2 diabetes mellitus	0.000246	0.00439	CbGeAlD
Zonisamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.00024	0.00428	CbGeAlD
Zonisamide—CA2—nephron tubule—type 2 diabetes mellitus	0.000232	0.00414	CbGeAlD
Zonisamide—MAOB—adipose tissue—type 2 diabetes mellitus	0.00023	0.00411	CbGeAlD
Zonisamide—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000223	0.00398	CbGeAlD
Zonisamide—CA4—adipose tissue—type 2 diabetes mellitus	0.000222	0.00396	CbGeAlD
Zonisamide—MAOA—kidney—type 2 diabetes mellitus	0.000218	0.00389	CbGeAlD
Zonisamide—MAOA—pancreas—type 2 diabetes mellitus	0.000217	0.00386	CbGeAlD
Zonisamide—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000212	0.00379	CbGeAlD
Zonisamide—AOX1—liver—type 2 diabetes mellitus	0.00021	0.00374	CbGeAlD
Zonisamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000209	0.00372	CbGeAlD
Zonisamide—CA2—kidney—type 2 diabetes mellitus	0.000204	0.00364	CbGeAlD
Zonisamide—CA2—pancreas—type 2 diabetes mellitus	0.000203	0.00362	CbGeAlD
Zonisamide—CA1—liver—type 2 diabetes mellitus	0.000199	0.00355	CbGeAlD
Zonisamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000199	0.00355	CbGeAlD
Zonisamide—MAOA—adipose tissue—type 2 diabetes mellitus	0.000197	0.00351	CbGeAlD
Zonisamide—CA2—adipose tissue—type 2 diabetes mellitus	0.000184	0.00328	CbGeAlD
Zonisamide—MAOB—liver—type 2 diabetes mellitus	0.000162	0.00288	CbGeAlD
Zonisamide—CYP2C19—liver—type 2 diabetes mellitus	0.000141	0.00251	CbGeAlD
Zonisamide—MAOA—liver—type 2 diabetes mellitus	0.000138	0.00246	CbGeAlD
Zonisamide—CYP3A4—kidney—type 2 diabetes mellitus	0.000132	0.00235	CbGeAlD
Zonisamide—CA2—liver—type 2 diabetes mellitus	0.000129	0.0023	CbGeAlD
Zonisamide—CYP3A4—liver—type 2 diabetes mellitus	8.32e-05	0.00148	CbGeAlD
Zonisamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000404	CcSEcCtD
Zonisamide—Myalgia—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000404	CcSEcCtD
Zonisamide—Shock—Metformin—type 2 diabetes mellitus	6.25e-05	0.000404	CcSEcCtD
Zonisamide—Insomnia—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000403	CcSEcCtD
Zonisamide—Malaise—Losartan—type 2 diabetes mellitus	6.24e-05	0.000403	CcSEcCtD
Zonisamide—Anxiety—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000403	CcSEcCtD
Zonisamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.23e-05	0.000402	CcSEcCtD
Zonisamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.23e-05	0.000402	CcSEcCtD
Zonisamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.22e-05	0.000402	CcSEcCtD
Zonisamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000402	CcSEcCtD
Zonisamide—Vertigo—Losartan—type 2 diabetes mellitus	6.21e-05	0.000401	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000401	CcSEcCtD
Zonisamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.21e-05	0.000401	CcSEcCtD
Zonisamide—Somnolence—Valsartan—type 2 diabetes mellitus	6.2e-05	0.000401	CcSEcCtD
Zonisamide—Syncope—Losartan—type 2 diabetes mellitus	6.2e-05	0.0004	CcSEcCtD
Zonisamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.19e-05	0.0004	CcSEcCtD
Zonisamide—Leukopenia—Losartan—type 2 diabetes mellitus	6.19e-05	0.0004	CcSEcCtD
Zonisamide—Discomfort—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000399	CcSEcCtD
Zonisamide—Skin disorder—Metformin—type 2 diabetes mellitus	6.17e-05	0.000399	CcSEcCtD
Zonisamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000397	CcSEcCtD
Zonisamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.14e-05	0.000397	CcSEcCtD
Zonisamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000397	CcSEcCtD
Zonisamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000396	CcSEcCtD
Zonisamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.12e-05	0.000395	CcSEcCtD
Zonisamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000395	CcSEcCtD
Zonisamide—Palpitations—Losartan—type 2 diabetes mellitus	6.11e-05	0.000395	CcSEcCtD
Zonisamide—Nausea—Glimepiride—type 2 diabetes mellitus	6.09e-05	0.000393	CcSEcCtD
Zonisamide—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.08e-05	0.000392	CcSEcCtD
Zonisamide—Nausea—Sitagliptin—type 2 diabetes mellitus	6.07e-05	0.000392	CcSEcCtD
Zonisamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000392	CcSEcCtD
Zonisamide—Asthenia—Glyburide—type 2 diabetes mellitus	6.07e-05	0.000392	CcSEcCtD
Zonisamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.07e-05	0.000392	CcSEcCtD
Zonisamide—Anorexia—Metformin—type 2 diabetes mellitus	6.06e-05	0.000391	CcSEcCtD
Zonisamide—Cough—Losartan—type 2 diabetes mellitus	6.03e-05	0.00039	CcSEcCtD
Zonisamide—Urticaria—Gliclazide—type 2 diabetes mellitus	6.03e-05	0.00039	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000389	CcSEcCtD
Zonisamide—Alopecia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000389	CcSEcCtD
Zonisamide—Fatigue—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000389	CcSEcCtD
Zonisamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6e-05	0.000388	CcSEcCtD
Zonisamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6e-05	0.000388	CcSEcCtD
Zonisamide—Oedema—Irbesartan—type 2 diabetes mellitus	6e-05	0.000387	CcSEcCtD
Zonisamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000387	CcSEcCtD
Zonisamide—Pruritus—Glyburide—type 2 diabetes mellitus	5.98e-05	0.000386	CcSEcCtD
Zonisamide—Mental disorder—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000385	CcSEcCtD
Zonisamide—Constipation—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000385	CcSEcCtD
Zonisamide—Infection—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000385	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000384	CcSEcCtD
Zonisamide—Fatigue—Orlistat—type 2 diabetes mellitus	5.94e-05	0.000384	CcSEcCtD
Zonisamide—Hypotension—Metformin—type 2 diabetes mellitus	5.94e-05	0.000383	CcSEcCtD
Zonisamide—Malnutrition—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000383	CcSEcCtD
Zonisamide—Shock—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000381	CcSEcCtD
Zonisamide—Myalgia—Losartan—type 2 diabetes mellitus	5.89e-05	0.00038	CcSEcCtD
Zonisamide—Arthralgia—Losartan—type 2 diabetes mellitus	5.89e-05	0.00038	CcSEcCtD
Zonisamide—Chest pain—Losartan—type 2 diabetes mellitus	5.89e-05	0.00038	CcSEcCtD
Zonisamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.88e-05	0.00038	CcSEcCtD
Zonisamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.00038	CcSEcCtD
Zonisamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000379	CcSEcCtD
Zonisamide—Anxiety—Losartan—type 2 diabetes mellitus	5.87e-05	0.000379	CcSEcCtD
Zonisamide—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000378	CcSEcCtD
Zonisamide—Rash—Bromocriptine—type 2 diabetes mellitus	5.83e-05	0.000377	CcSEcCtD
Zonisamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.83e-05	0.000376	CcSEcCtD
Zonisamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000376	CcSEcCtD
Zonisamide—Tension—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000376	CcSEcCtD
Zonisamide—Discomfort—Losartan—type 2 diabetes mellitus	5.82e-05	0.000376	CcSEcCtD
Zonisamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000375	CcSEcCtD
Zonisamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000374	CcSEcCtD
Zonisamide—Headache—Bromocriptine—type 2 diabetes mellitus	5.8e-05	0.000374	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.79e-05	0.000374	CcSEcCtD
Zonisamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.79e-05	0.000374	CcSEcCtD
Zonisamide—Nervousness—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000372	CcSEcCtD
Zonisamide—Dry mouth—Losartan—type 2 diabetes mellitus	5.76e-05	0.000372	CcSEcCtD
Zonisamide—Anorexia—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000369	CcSEcCtD
Zonisamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.71e-05	0.000368	CcSEcCtD
Zonisamide—Paraesthesia—Metformin—type 2 diabetes mellitus	5.71e-05	0.000368	CcSEcCtD
Zonisamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000368	CcSEcCtD
Zonisamide—Confusional state—Losartan—type 2 diabetes mellitus	5.69e-05	0.000367	CcSEcCtD
Zonisamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000367	CcSEcCtD
Zonisamide—Dyspnoea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000366	CcSEcCtD
Zonisamide—Somnolence—Metformin—type 2 diabetes mellitus	5.65e-05	0.000365	CcSEcCtD
Zonisamide—Oedema—Losartan—type 2 diabetes mellitus	5.64e-05	0.000364	CcSEcCtD
Zonisamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.64e-05	0.000364	CcSEcCtD
Zonisamide—Infection—Losartan—type 2 diabetes mellitus	5.61e-05	0.000362	CcSEcCtD
Zonisamide—Hypotension—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000362	CcSEcCtD
Zonisamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.6e-05	0.000361	CcSEcCtD
Zonisamide—Dyspepsia—Metformin—type 2 diabetes mellitus	5.59e-05	0.000361	CcSEcCtD
Zonisamide—Tremor—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000359	CcSEcCtD
Zonisamide—Shock—Losartan—type 2 diabetes mellitus	5.55e-05	0.000359	CcSEcCtD
Zonisamide—Urticaria—Valsartan—type 2 diabetes mellitus	5.54e-05	0.000358	CcSEcCtD
Zonisamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.53e-05	0.000357	CcSEcCtD
Zonisamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.53e-05	0.000357	CcSEcCtD
Zonisamide—Decreased appetite—Metformin—type 2 diabetes mellitus	5.52e-05	0.000357	CcSEcCtD
Zonisamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000356	CcSEcCtD
Zonisamide—Tachycardia—Losartan—type 2 diabetes mellitus	5.51e-05	0.000356	CcSEcCtD
Zonisamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000355	CcSEcCtD
Zonisamide—Nausea—Bromocriptine—type 2 diabetes mellitus	5.5e-05	0.000355	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.49e-05	0.000354	CcSEcCtD
Zonisamide—Fatigue—Metformin—type 2 diabetes mellitus	5.48e-05	0.000354	CcSEcCtD
Zonisamide—Urticaria—Orlistat—type 2 diabetes mellitus	5.48e-05	0.000354	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.000353	CcSEcCtD
Zonisamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.46e-05	0.000352	CcSEcCtD
Zonisamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.45e-05	0.000352	CcSEcCtD
Zonisamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.45e-05	0.000352	CcSEcCtD
Zonisamide—Asthenia—Gliclazide—type 2 diabetes mellitus	5.45e-05	0.000352	CcSEcCtD
Zonisamide—Agitation—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000352	CcSEcCtD
Zonisamide—Constipation—Metformin—type 2 diabetes mellitus	5.43e-05	0.000351	CcSEcCtD
Zonisamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.38e-05	0.000348	CcSEcCtD
Zonisamide—Anorexia—Losartan—type 2 diabetes mellitus	5.38e-05	0.000347	CcSEcCtD
Zonisamide—Vomiting—Glyburide—type 2 diabetes mellitus	5.38e-05	0.000347	CcSEcCtD
Zonisamide—Pruritus—Gliclazide—type 2 diabetes mellitus	5.37e-05	0.000347	CcSEcCtD
Zonisamide—Malaise—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000345	CcSEcCtD
Zonisamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000345	CcSEcCtD
Zonisamide—Rash—Glyburide—type 2 diabetes mellitus	5.33e-05	0.000344	CcSEcCtD
Zonisamide—Somnolence—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000344	CcSEcCtD
Zonisamide—Dermatitis—Glyburide—type 2 diabetes mellitus	5.33e-05	0.000344	CcSEcCtD
Zonisamide—Vertigo—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000344	CcSEcCtD
Zonisamide—Syncope—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000343	CcSEcCtD
Zonisamide—Leukopenia—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000343	CcSEcCtD
Zonisamide—Headache—Glyburide—type 2 diabetes mellitus	5.3e-05	0.000342	CcSEcCtD
Zonisamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000341	CcSEcCtD
Zonisamide—Hypotension—Losartan—type 2 diabetes mellitus	5.27e-05	0.000341	CcSEcCtD
Zonisamide—Palpitations—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000338	CcSEcCtD
Zonisamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.24e-05	0.000338	CcSEcCtD
Zonisamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000337	CcSEcCtD
Zonisamide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000337	CcSEcCtD
Zonisamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.2e-05	0.000336	CcSEcCtD
Zonisamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.2e-05	0.000336	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000334	CcSEcCtD
Zonisamide—Cough—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000334	CcSEcCtD
Zonisamide—Fatigue—Irbesartan—type 2 diabetes mellitus	5.17e-05	0.000334	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.14e-05	0.000332	CcSEcCtD
Zonisamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000332	CcSEcCtD
Zonisamide—Convulsion—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000332	CcSEcCtD
Zonisamide—Constipation—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000331	CcSEcCtD
Zonisamide—Insomnia—Losartan—type 2 diabetes mellitus	5.1e-05	0.00033	CcSEcCtD
Zonisamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000328	CcSEcCtD
Zonisamide—Paraesthesia—Losartan—type 2 diabetes mellitus	5.07e-05	0.000327	CcSEcCtD
Zonisamide—Urticaria—Metformin—type 2 diabetes mellitus	5.05e-05	0.000326	CcSEcCtD
Zonisamide—Arthralgia—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000326	CcSEcCtD
Zonisamide—Myalgia—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000326	CcSEcCtD
Zonisamide—Chest pain—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000326	CcSEcCtD
Zonisamide—Dyspnoea—Losartan—type 2 diabetes mellitus	5.03e-05	0.000325	CcSEcCtD
Zonisamide—Anxiety—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000325	CcSEcCtD
Zonisamide—Nausea—Glyburide—type 2 diabetes mellitus	5.02e-05	0.000324	CcSEcCtD
Zonisamide—Abdominal pain—Metformin—type 2 diabetes mellitus	5.02e-05	0.000324	CcSEcCtD
Zonisamide—Dizziness—Gliclazide—type 2 diabetes mellitus	5.02e-05	0.000324	CcSEcCtD
Zonisamide—Somnolence—Losartan—type 2 diabetes mellitus	5.02e-05	0.000324	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000324	CcSEcCtD
Zonisamide—Asthenia—Valsartan—type 2 diabetes mellitus	5.01e-05	0.000323	CcSEcCtD
Zonisamide—Discomfort—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000322	CcSEcCtD
Zonisamide—Dyspepsia—Losartan—type 2 diabetes mellitus	4.97e-05	0.000321	CcSEcCtD
Zonisamide—Asthenia—Orlistat—type 2 diabetes mellitus	4.95e-05	0.000319	CcSEcCtD
Zonisamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000319	CcSEcCtD
Zonisamide—Pruritus—Valsartan—type 2 diabetes mellitus	4.94e-05	0.000319	CcSEcCtD
Zonisamide—Dry mouth—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000319	CcSEcCtD
Zonisamide—Decreased appetite—Losartan—type 2 diabetes mellitus	4.91e-05	0.000317	CcSEcCtD
Zonisamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000317	CcSEcCtD
Zonisamide—Confusional state—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000315	CcSEcCtD
Zonisamide—Pruritus—Orlistat—type 2 diabetes mellitus	4.88e-05	0.000315	CcSEcCtD
Zonisamide—Fatigue—Losartan—type 2 diabetes mellitus	4.87e-05	0.000314	CcSEcCtD
Zonisamide—Oedema—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000312	CcSEcCtD
Zonisamide—Vomiting—Gliclazide—type 2 diabetes mellitus	4.83e-05	0.000312	CcSEcCtD
Zonisamide—Constipation—Losartan—type 2 diabetes mellitus	4.83e-05	0.000312	CcSEcCtD
Zonisamide—Rash—Gliclazide—type 2 diabetes mellitus	4.79e-05	0.000309	CcSEcCtD
Zonisamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.78e-05	0.000309	CcSEcCtD
Zonisamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000308	CcSEcCtD
Zonisamide—Urticaria—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000308	CcSEcCtD
Zonisamide—Shock—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000307	CcSEcCtD
Zonisamide—Headache—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000307	CcSEcCtD
Zonisamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000306	CcSEcCtD
Zonisamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000306	CcSEcCtD
Zonisamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000306	CcSEcCtD
Zonisamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000306	CcSEcCtD
Zonisamide—Tachycardia—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000305	CcSEcCtD
Zonisamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.72e-05	0.000305	CcSEcCtD
Zonisamide—Skin disorder—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000304	CcSEcCtD
Zonisamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000302	CcSEcCtD
Zonisamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.65e-05	0.0003	CcSEcCtD
Zonisamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.61e-05	0.000298	CcSEcCtD
Zonisamide—Dizziness—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000298	CcSEcCtD
Zonisamide—Anorexia—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000298	CcSEcCtD
Zonisamide—Dizziness—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000294	CcSEcCtD
Zonisamide—Asthenia—Metformin—type 2 diabetes mellitus	4.56e-05	0.000294	CcSEcCtD
Zonisamide—Hypotension—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000292	CcSEcCtD
Zonisamide—Nausea—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000291	CcSEcCtD
Zonisamide—Pruritus—Metformin—type 2 diabetes mellitus	4.5e-05	0.00029	CcSEcCtD
Zonisamide—Urticaria—Losartan—type 2 diabetes mellitus	4.48e-05	0.00029	CcSEcCtD
Zonisamide—Abdominal pain—Losartan—type 2 diabetes mellitus	4.46e-05	0.000288	CcSEcCtD
Zonisamide—Body temperature increased—Losartan—type 2 diabetes mellitus	4.46e-05	0.000288	CcSEcCtD
Zonisamide—Vomiting—Valsartan—type 2 diabetes mellitus	4.44e-05	0.000287	CcSEcCtD
Zonisamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000285	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000285	CcSEcCtD
Zonisamide—Rash—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000284	CcSEcCtD
Zonisamide—Dermatitis—Valsartan—type 2 diabetes mellitus	4.4e-05	0.000284	CcSEcCtD
Zonisamide—Vomiting—Orlistat—type 2 diabetes mellitus	4.38e-05	0.000283	CcSEcCtD
Zonisamide—Insomnia—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000283	CcSEcCtD
Zonisamide—Headache—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000282	CcSEcCtD
Zonisamide—Diarrhoea—Metformin—type 2 diabetes mellitus	4.35e-05	0.000281	CcSEcCtD
Zonisamide—Rash—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000281	CcSEcCtD
Zonisamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000281	CcSEcCtD
Zonisamide—Dermatitis—Orlistat—type 2 diabetes mellitus	4.34e-05	0.00028	CcSEcCtD
Zonisamide—Headache—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000279	CcSEcCtD
Zonisamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000279	CcSEcCtD
Zonisamide—Asthenia—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000278	CcSEcCtD
Zonisamide—Somnolence—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000278	CcSEcCtD
Zonisamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000275	CcSEcCtD
Zonisamide—Pruritus—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000274	CcSEcCtD
Zonisamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000272	CcSEcCtD
Zonisamide—Dizziness—Metformin—type 2 diabetes mellitus	4.2e-05	0.000271	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.18e-05	0.00027	CcSEcCtD
Zonisamide—Fatigue—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000269	CcSEcCtD
Zonisamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.16e-05	0.000269	CcSEcCtD
Zonisamide—Nausea—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000268	CcSEcCtD
Zonisamide—Constipation—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000267	CcSEcCtD
Zonisamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000265	CcSEcCtD
Zonisamide—Nausea—Orlistat—type 2 diabetes mellitus	4.1e-05	0.000264	CcSEcCtD
Zonisamide—Asthenia—Losartan—type 2 diabetes mellitus	4.05e-05	0.000261	CcSEcCtD
Zonisamide—Vomiting—Metformin—type 2 diabetes mellitus	4.04e-05	0.000261	CcSEcCtD
Zonisamide—Rash—Metformin—type 2 diabetes mellitus	4.01e-05	0.000259	CcSEcCtD
Zonisamide—Dermatitis—Metformin—type 2 diabetes mellitus	4e-05	0.000258	CcSEcCtD
Zonisamide—Pruritus—Losartan—type 2 diabetes mellitus	3.99e-05	0.000258	CcSEcCtD
Zonisamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000258	CcSEcCtD
Zonisamide—Headache—Metformin—type 2 diabetes mellitus	3.98e-05	0.000257	CcSEcCtD
Zonisamide—Dizziness—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000256	CcSEcCtD
Zonisamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000256	CcSEcCtD
Zonisamide—Diarrhoea—Losartan—type 2 diabetes mellitus	3.86e-05	0.000249	CcSEcCtD
Zonisamide—Urticaria—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000248	CcSEcCtD
Zonisamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000247	CcSEcCtD
Zonisamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000247	CcSEcCtD
Zonisamide—Vomiting—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000246	CcSEcCtD
Zonisamide—Rash—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000244	CcSEcCtD
Zonisamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000244	CcSEcCtD
Zonisamide—Nausea—Metformin—type 2 diabetes mellitus	3.77e-05	0.000244	CcSEcCtD
Zonisamide—Headache—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000243	CcSEcCtD
Zonisamide—Dizziness—Losartan—type 2 diabetes mellitus	3.73e-05	0.000241	CcSEcCtD
Zonisamide—Vomiting—Losartan—type 2 diabetes mellitus	3.59e-05	0.000232	CcSEcCtD
Zonisamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.57e-05	0.00023	CcSEcCtD
Zonisamide—Nausea—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.00023	CcSEcCtD
Zonisamide—Rash—Losartan—type 2 diabetes mellitus	3.56e-05	0.00023	CcSEcCtD
Zonisamide—Dermatitis—Losartan—type 2 diabetes mellitus	3.55e-05	0.00023	CcSEcCtD
Zonisamide—Headache—Losartan—type 2 diabetes mellitus	3.54e-05	0.000228	CcSEcCtD
Zonisamide—Asthenia—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000224	CcSEcCtD
Zonisamide—Pruritus—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000221	CcSEcCtD
Zonisamide—Nausea—Losartan—type 2 diabetes mellitus	3.35e-05	0.000216	CcSEcCtD
Zonisamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000214	CcSEcCtD
Zonisamide—Dizziness—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000207	CcSEcCtD
Zonisamide—Vomiting—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000199	CcSEcCtD
Zonisamide—Rash—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000197	CcSEcCtD
Zonisamide—Dermatitis—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000197	CcSEcCtD
Zonisamide—Headache—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000196	CcSEcCtD
Zonisamide—Nausea—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000186	CcSEcCtD
Zonisamide—MAOA—Metabolism—ADRA2A—type 2 diabetes mellitus	4.05e-06	3.54e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—type 2 diabetes mellitus	4.04e-06	3.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	4.01e-06	3.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	4.01e-06	3.5e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—INS—type 2 diabetes mellitus	3.99e-06	3.48e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPARG—type 2 diabetes mellitus	3.99e-06	3.48e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ALB—type 2 diabetes mellitus	3.98e-06	3.47e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AGT—type 2 diabetes mellitus	3.95e-06	3.45e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	3.95e-06	3.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—INS—type 2 diabetes mellitus	3.91e-06	3.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	3.91e-06	3.41e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP2E1—type 2 diabetes mellitus	3.89e-06	3.4e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CALM1—type 2 diabetes mellitus	3.88e-06	3.39e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—APOE—type 2 diabetes mellitus	3.87e-06	3.38e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A2—type 2 diabetes mellitus	3.85e-06	3.36e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A1—type 2 diabetes mellitus	3.85e-06	3.36e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—APOA1—type 2 diabetes mellitus	3.83e-06	3.34e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ALB—type 2 diabetes mellitus	3.82e-06	3.33e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	3.81e-06	3.32e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.81e-06	3.32e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP3A4—type 2 diabetes mellitus	3.76e-06	3.28e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—type 2 diabetes mellitus	3.75e-06	3.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	3.75e-06	3.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	3.73e-06	3.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	3.73e-06	3.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	3.73e-06	3.26e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GCG—type 2 diabetes mellitus	3.69e-06	3.22e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A4—type 2 diabetes mellitus	3.69e-06	3.22e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ALB—type 2 diabetes mellitus	3.66e-06	3.19e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.65e-06	3.18e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	3.65e-06	3.18e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ALB—type 2 diabetes mellitus	3.59e-06	3.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	3.58e-06	3.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	3.58e-06	3.12e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	3.58e-06	3.12e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—INS—type 2 diabetes mellitus	3.51e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	3.5e-06	3.05e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.5e-06	3.05e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	3.48e-06	3.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	3.44e-06	3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	3.44e-06	3e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.43e-06	2.99e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NOS3—type 2 diabetes mellitus	3.43e-06	2.99e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	3.38e-06	2.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.38e-06	2.95e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPARG—type 2 diabetes mellitus	3.37e-06	2.94e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	3.34e-06	2.91e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	3.33e-06	2.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	3.33e-06	2.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	3.33e-06	2.9e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—INS—type 2 diabetes mellitus	3.31e-06	2.88e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	3.27e-06	2.86e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	3.27e-06	2.86e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.22e-06	2.81e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—type 2 diabetes mellitus	3.22e-06	2.81e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	3.2e-06	2.79e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	3.19e-06	2.78e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNB3—type 2 diabetes mellitus	3.18e-06	2.78e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.18e-06	2.78e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-06	2.76e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—type 2 diabetes mellitus	3.14e-06	2.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	3.13e-06	2.73e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAT—type 2 diabetes mellitus	3.13e-06	2.73e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	3.1e-06	2.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	3.1e-06	2.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.08e-06	2.69e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.08e-06	2.68e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	3.08e-06	2.68e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOB—type 2 diabetes mellitus	3.03e-06	2.65e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—type 2 diabetes mellitus	3.03e-06	2.64e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—type 2 diabetes mellitus	3.03e-06	2.64e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3e-06	2.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	2.96e-06	2.58e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—type 2 diabetes mellitus	2.95e-06	2.57e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	2.94e-06	2.56e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	2.93e-06	2.55e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.93e-06	2.55e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.9e-06	2.53e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NOS3—type 2 diabetes mellitus	2.9e-06	2.53e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—LPL—type 2 diabetes mellitus	2.9e-06	2.53e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	2.83e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	2.83e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	2.83e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	2.83e-06	2.47e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-06	2.47e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	2.81e-06	2.45e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CD36—type 2 diabetes mellitus	2.75e-06	2.4e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	2.73e-06	2.38e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	2.73e-06	2.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.72e-06	2.37e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-06	2.37e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	2.71e-06	2.37e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—type 2 diabetes mellitus	2.71e-06	2.36e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—type 2 diabetes mellitus	2.66e-06	2.32e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—type 2 diabetes mellitus	2.65e-06	2.31e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	2.64e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	2.64e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	2.64e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	2.64e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.64e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.63e-06	2.3e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-06	2.28e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	2.6e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.58e-06	2.25e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	2.56e-06	2.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	2.56e-06	2.23e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.55e-06	2.23e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	2.54e-06	2.21e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	2.54e-06	2.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	2.52e-06	2.2e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AGT—type 2 diabetes mellitus	2.48e-06	2.16e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	2.13e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOE—type 2 diabetes mellitus	2.43e-06	2.12e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	2.41e-06	2.11e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	2.41e-06	2.11e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	2.4e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-06	2.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	2.35e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.35e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	2.31e-06	2.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	2.31e-06	2.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	2.26e-06	1.97e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.25e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	2.25e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	2.25e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	2.25e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.24e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.24e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.24e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	2.23e-06	1.95e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-06	1.91e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	2.19e-06	1.91e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	2.17e-06	1.89e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.15e-06	1.88e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.15e-06	1.88e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-06	1.85e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—INS—type 2 diabetes mellitus	2.07e-06	1.81e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.07e-06	1.81e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.07e-06	1.81e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—type 2 diabetes mellitus	2.04e-06	1.78e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.03e-06	1.77e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.02e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	2.02e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	2.02e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	2.02e-06	1.76e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.98e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.96e-06	1.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.93e-06	1.69e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.92e-06	1.67e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	1.66e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—type 2 diabetes mellitus	1.88e-06	1.64e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.88e-06	1.64e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.84e-06	1.61e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.82e-06	1.59e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.82e-06	1.59e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	1.59e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	1.59e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.78e-06	1.55e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.77e-06	1.54e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.76e-06	1.54e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	1.75e-06	1.53e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.75e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.75e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.7e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.7e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.7e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.7e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	1.68e-06	1.46e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.45e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.63e-06	1.42e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	1.61e-06	1.4e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—type 2 diabetes mellitus	1.58e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.52e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.51e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.51e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.5e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.48e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.44e-06	1.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.42e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	1.41e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.4e-06	1.22e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.39e-06	1.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.39e-06	1.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.37e-06	1.2e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.36e-06	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.35e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.35e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.35e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.34e-06	1.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.34e-06	1.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-06	1.17e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	1.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.32e-06	1.15e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.3e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.3e-06	1.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-06	1.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.21e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.21e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.21e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.19e-06	1.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.18e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.17e-06	1.02e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.15e-06	1.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-06	1.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.15e-06	1e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.14e-06	9.91e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.11e-06	9.67e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.1e-06	9.56e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.1e-06	9.56e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.05e-06	9.17e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.05e-06	9.17e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1e-06	8.73e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	9.82e-07	8.57e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.06e-07	7.9e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.06e-07	7.9e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.02e-07	7.86e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	9e-07	7.85e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.9e-07	7.76e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	8.64e-07	7.53e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	8.61e-07	7.51e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	8.61e-07	7.51e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.4e-07	7.33e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	8.36e-07	7.29e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.25e-07	7.19e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.07e-07	7.04e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.05e-07	7.02e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	7.88e-07	6.87e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.84e-07	6.83e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.74e-07	6.75e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.42e-07	6.48e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.28e-07	6.35e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.05e-07	6.15e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.94e-07	6.05e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.91e-07	6.03e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.83e-07	5.96e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.02e-07	5.25e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.91e-07	5.15e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.41e-07	4.72e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.18e-07	4.52e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.18e-07	4.52e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.74e-07	4.13e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.96e-07	3.45e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-07	2.08e-06	CbGpPWpGaD
